A Multicenter Open-label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Investigate Efficacy, Safety and Pharmacokinetics after Dose Escalation in Japanese Subjects with Crohn's Disease

Update Il y a 4 ans
Reference: EUCTR2015-004121-13

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To investigate efficacy, safety and pharmacokinetics after dose escalation for the subjects who lost response to adalimumab in Japanese patients with Crohn's disease.


Inclusion criteria

  • Crohn’s Disease

Links